Amgen co-founder William K. Bowes Jr. stands watch over the Thousand Oaks campus. Amgen is officially in the biosimilar game. The Food and Drug Administration approved the Thousand Oaks-biotech giant’s Humira biosimilar Sept. 23, making it the first Amgen biosimilar approved for sale anywhere in the world. The approval could be a windfall for the…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
